Truist Securities Reiterates Buy Rating on iRhythm Technologies, Inc (IRTC)

Market Context

iRhythm Technologies, Inc operates in the Healthcare sector. The stock currently trades at $124.78 with a market capitalization of $5.4B. The stock has declined 22.5% over the past 52 weeks.

Analyst coverage from Truist Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for iRhythm Technologies, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for iRhythm Technologies, Inc

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 10, 2026	Truist Securities	Buy	N/A
Aug 07, 2026	Needham	Buy	N/A
Aug 07, 2026	Wells Fargo	Overweight	N/A
Aug 07, 2026	Evercore ISI Group	Outperform	N/A
Jul 23, 2026	Stephens & Co.	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View IRTC Stock Page